CLINICAL_TRIALS
trial_result
· 2021-02-21
Clinical Trial Update: A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects [Phase 2]
Summary
Phase 2 pharmacokinetic trial of MC2-01 Cream in adolescents with psoriasis vulgaris has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MC2 Therapeutics | Conditions: Psoriasis Vulgaris | Phase 2 | Status: TERMINATED | Results posted: 2021-02-21